![](/static/media/logo.jpg)
An International Publisher for Academic and Scientific Journals
Author Login
Scholars Academic Journal of Pharmacy | Volume-8 | Issue-01
Phenytoin Induced Parkinsonism: A Case Study
Das V, Benjamin B
Published: Jan. 30, 2019 |
149
110
DOI: 10.21276/sajp.2019.8.1.4
Pages: 20-22
Downloads
Abstract
A seizure is a paroxysmal event due to abnormal excessive or synchronous neuronal activity in the brain. Epilepsy is a
condition in which the patient has recurrent seizure due to a chronic, underlying process. Parkinsonism is the second
common neurodegenerative disorder followed by Alzheimer's disease. The Diagnostic and Statistical Manual of
Mental Disorders, fifth edition (DSM-V). Defines Drug Induced Parkinsonism (DIP) as the presence of resting tremor,
muscular rigidity, akinesia or bradykinesia developing within few weeks of starting or raising the dose of medication
or after reducing the dose of antiparkinsonian agent. A male patient of age 75years was admitted with complaints of
generalized weakness and mild fever for 2 days. While assessing the patient, it was found that the patient has the
history of complex partial seizures and is on phenytoin. The drug blood level which was more than the therapeutic
level of the drug and the radiologic finding reinforce the findings. The adverse effect was confirmed using Narango’s
Algorithm and WHO-UMC Causality system. Even though the radiological findings are still persisting, the clinical
symptoms have been relieving with the stoppage of drug.